News Round-Up
(For more, follow @Pharmed_Out on Twitter!)
July 30
"A Congressional Attempt To Speed The Development Of Lifesaving Treatments", The Diane Rehm Show
July 27
"Disclosure of Boxed Warnings to Research Participants" by Tanya Bhattacharya, Debra G. Tice, Pranathi Lingam, Aleksandra Florek, Eileen M. Yates, Sigmund Weitzman, and Steven M. Belknap (JAMA Internal Medicine)
"UK May Require Doctors to Report Their Financial Ties to Drug Makers" by Ed Silverman (WSJ Pharmalot)
July 23
"Most Americans say Drug Costs are Unreasonable and They Blame Pharma" by Ed Silverman (WSJ Pharmalot)
"Drug Prices Soar, Prompting Calls for Justification" by Andrew Pollack (New York Times)
"One big myth about medicine: We know how drugs work" by Carolyn Johnson (Washington Post)
July 22
"Scientists Are Hoarding Data And It’s Ruining Medical Research" by Ben Goldacre (Buzzfeed News)
"More Than 100 Doctors Tell Big Pharma To Stop Making Cancer Drugs So Expensive" by Tara Culp-Ressler (ThinkProgress)
"Are Boastful Claims in Drug Ads Seen as Proxies for Effectiveness?" by Ed Silverman (WSJ Pharmalot)
July 21
"Rising U.S. Drug Prices Are Focus of Research Grant" by Peter Loftus (Wall Street Journal)
July 20
"Judging a Pill by Its Color" by Ann Lukits (Wall Street Journal)
July 16
"To Support Physician Decision-Making, Re-Evaluate Industry Funding Of Science" by Christopher Robertson (Health Affairs)
July 14
"Conflicts of Interest on Institutional Review Boards Remain Problematic" by Ed Silverman (WSJ Pharmalot)
July 13
"Gilead Pills Priced at $1,000 a Day Are Found Cost-Effective" by Doni Bloomfield (Bloomberg)
"Making The Cut: Why choosing the right surgeon matters even more than you know" by Marshall Allen and Olga Pierce (ProPublica)
July 12
"Popular blood thinner causing deaths, injuries in nursing homes" by Charles Ornstein (Washington Post)
July 10
"This bill promises to speed up drug approvals so much that it’s making people uncomfortable" by Carolyn Johnson (Washington Post)
"Harvard researchers tested 23 online ‘symptom checkers.’ Most got failing grades. Here’s how they stack up." by Ariana Eunjung Cha (Washington Post)
"The Double Mastectomy Rebellion" by Lucette Lagnado (Wall Street Journal)
July 8
"Health Buzz: Study Concludes Mammograms Lead to Overdiagnosis" by Samantha Costa (U.S. News and World Report)
July 7
"Improve Health Care: Track Artificial Hips" by Peter R. Orszag (Bloomberg View)
"Heroin Use Surges, Especially Among Women And Whites" by Richard Harris (NPR)
July 6
"Transparency Program Obscures Pharma Payments to Nurses, Physician Assistants" by Charles Ornstein (ProPublica)
"Evaluation of Flibanserin: Science and Advocacy at the FDA" by Walid F. Gellad, Kathryn E. Flynn, G. Caleb Alexander (JAMA)
"'Female Viagra' a political tightrope for FDA, advisors warn" by Melissa Healy (L.A. Times)
July 1
"Industry Payments To Doctors Are Ingrained, Federal Data Show" by Charles Ornstein and Ryan Grochowski Jones (NPR)
June 30
"Hotel Workers Want to End Pharma Support of Continuing Medical Ed" by Ed Silverman (WSJ Pharmalot)
|